Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
bad upper respiratory infection; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of upper respiratory tract infection in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. Concurrent medical conditions included sinus disorder (patient's sinuses are a mess). On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced upper respiratory tract infection (Verbatim: bad upper respiratory infection). The outcome of the upper respiratory tract infection was not reported. It was unknown if the reporter considered the upper respiratory tract infection to be related to RSV vaccine. It was unknown if the company considered the upper respiratory tract infection to be related to RSV vaccine. Additional Information: GSK receipt date: 25-JUL-2025 This case was reported by a patient via interactive digital media. The patient had the vaccine but felt that he/she had a really bad upper respiratory infection. The patient felt like crap and his/her sinuses were a mess.
Sinus disorder (patient's sinuses are a mess)